BIS(MALTOLATO)OXOVANADIUM

O=[V++].CC1=C([O-])C(=O)C=CO1.CC2=C([O-])C(=O)C=CO2

InChIKey=XUOLEICXAPEOSI-UHFFFAOYSA-L

InChI=1S/2C6H6O3.O.V/c2*1-4-6(8)5(7)2-3-9-4;;/h2*2-3,8H,1H3;;/q;;;+2/p-2

Targets

Primary Target	Pharmacology	Condition	Potency
Tyrosine-protein phosphatase non-receptor type 1 4 Target ID: P18031 Gene ID: 5770.0 Gene Symbol: PTPN1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/18728000 \| https://www.ncbi.nlm.nih.gov/pubmed/12888267	Inhibitor 8297		0.86 µM [IC50]

PubMed

Title	Date	PubMed
Effect of vanadium on insulin sensitivity and appetite.	2001 Jun	11398143
Effect of bis (maltolato) oxovanadium (BMOV) in uric acid and sodium arsenite-induced vascular endothelial dysfunction in rats.	2008 Aug 29	17658639

Name

Type

Language

BIS(MALTOLATO)OXOVANADIUM

Common Name

English

VO(MA)2

Common Name

English

BMOV

Common Name

English

BIS((2-METHYL-4-OXO-PYRAN-3-YL)OXY)-OXO-VANADIUM

Systematic Name

English

VANADIUM, BIS(3-HYDROXY-2-METHYL-4H-PYRAN-4-ONATO-O3,O4)OXO-, (SP-5-31)-

Systematic Name

English

Code System Code Type Description

EPA CompTox

DTXSID50191593